chr6-123377874-A-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006073.4(TRDN):āc.1211T>Gā(p.Val404Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.149 in 1,533,254 control chromosomes in the GnomAD database, including 18,325 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_006073.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRDN | NM_006073.4 | c.1211T>G | p.Val404Gly | missense_variant | 17/41 | ENST00000334268.9 | |
TRDN | NM_001251987.2 | c.1214T>G | p.Val405Gly | missense_variant | 17/21 | ||
TRDN | NM_001407315.1 | c.1154T>G | p.Val385Gly | missense_variant | 16/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRDN | ENST00000334268.9 | c.1211T>G | p.Val404Gly | missense_variant | 17/41 | 1 | NM_006073.4 | A2 | |
TRDN | ENST00000662930.1 | c.1214T>G | p.Val405Gly | missense_variant | 17/21 |
Frequencies
GnomAD3 genomes AF: 0.164 AC: 24966AN: 152002Hom.: 2175 Cov.: 32
GnomAD3 exomes AF: 0.152 AC: 28782AN: 188752Hom.: 2432 AF XY: 0.158 AC XY: 16056AN XY: 101424
GnomAD4 exome AF: 0.148 AC: 203831AN: 1381138Hom.: 16150 Cov.: 28 AF XY: 0.151 AC XY: 103345AN XY: 686038
GnomAD4 genome AF: 0.164 AC: 24961AN: 152116Hom.: 2175 Cov.: 32 AF XY: 0.165 AC XY: 12257AN XY: 74350
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | Val404Gly in exon 17 of TRDN: This variant is not expected to have clinical sign ificance because it has been identified in 18.9% (671/3550) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs28494009). - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 26, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 10, 2023 | - - |
Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 23, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at